Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study
- PMID: 18206247
- PMCID: PMC5598081
- DOI: 10.1016/j.jad.2007.12.228
Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study
Abstract
Background: Perinatal major depressive disorder (MDD), including antenatal and postpartum depression, is common and has serious consequences. This study was designed to investigate the feasibility, safety, and efficacy of omega-3 fatty acids for perinatal depression in addition to supportive psychotherapy.
Methods: Perinatal women with MDD were randomized to eicosapentaenoic (EPA) and docosahexaenoic acids (DHA), 1.9g/day, or placebo for 8weeks. A manualized supportive psychotherapy was provided to all subjects. Symptoms were assessed with the Hamilton Rating Scale for Depression (HAM-D) and Edinburgh Postnatal Depression Scale (EPDS) biweekly.
Results: Fifty-nine women enrolled; N = 51 had two data collection points that allowed for evaluation of efficacy. Omega-3 fatty acids were well tolerated. Participants in both groups experienced significant decreases in EPDS and HAM-D scores (p<.0001) from baseline. We did not find a benefit of omega-3 fatty acids over placebo. Dietary omega-3 fatty acid intake was low among participants.
Limitations: The ability to detect an effect of omega-3 fatty acids may have been limited by sample size, study length, or dose. The benefits of supportive psychotherapy may have limited the ability to detect an effect of omega-3 fatty acids.
Conclusions: There was no significant difference between omega-3 fatty acids and placebo in this study in which all participants received supportive psychotherapy. The manualized supportive psychotherapy warrants further study. The low intake of dietary omega-3 fatty acids among participants is of concern, in consideration of the widely established health advantages in utero and in infants.
Similar articles
-
Supportive psychotherapy for perinatal depression: preliminary data for adherence and response.Depress Anxiety. 2010;27(1):39-45. doi: 10.1002/da.20596. Depress Anxiety. 2010. PMID: 19691033 Clinical Trial.
-
Tolerability of omega-3 fatty acid supplements in perinatal women.Prostaglandins Leukot Essent Fatty Acids. 2007 Oct-Nov;77(3-4):203-8. doi: 10.1016/j.plefa.2007.09.004. Epub 2007 Nov 5. Prostaglandins Leukot Essent Fatty Acids. 2007. PMID: 17981449 Clinical Trial.
-
Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.J Clin Psychiatry. 2008 Apr;69(4):644-51. doi: 10.4088/jcp.v69n0418. J Clin Psychiatry. 2008. PMID: 18370571 Clinical Trial.
-
Complementary and alternative medicine for perinatal depression.J Affect Disord. 2009 Jan;112(1-3):1-10. doi: 10.1016/j.jad.2008.06.017. Epub 2008 Aug 8. J Affect Disord. 2009. PMID: 18692251 Review.
-
Role of omega-3 fatty acids as a treatment for depression in the perinatal period.Aust N Z J Psychiatry. 2005 Apr;39(4):274-80. doi: 10.1080/j.1440-1614.2005.01565.x. Aust N Z J Psychiatry. 2005. PMID: 15777365 Review.
Cited by
-
Nutrition and the psychoneuroimmunology of postpartum depression.Nutr Res Rev. 2012 Jun;25(1):180-92. doi: 10.1017/S0954422412000091. Nutr Res Rev. 2012. PMID: 22853878 Free PMC article. Review.
-
Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses.Neuropsychiatr Dis Treat. 2023 Jan 5;19:1-25. doi: 10.2147/NDT.S385117. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 36636142 Free PMC article. Review.
-
PPAR and functional foods: Rationale for natural neurosteroid-based interventions for postpartum depression.Neurobiol Stress. 2020 Apr 19;12:100222. doi: 10.1016/j.ynstr.2020.100222. eCollection 2020 May. Neurobiol Stress. 2020. PMID: 32426424 Free PMC article.
-
Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression.Br J Psychiatry. 2016 Sep;209(3):192-201. doi: 10.1192/bjp.bp.114.160242. Epub 2016 Apr 21. Br J Psychiatry. 2016. PMID: 27103682 Free PMC article. Review.
-
Antioxidants as potential therapeutics for neuropsychiatric disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:214-23. doi: 10.1016/j.pnpbp.2012.10.017. Epub 2012 Nov 2. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23123357 Free PMC article. Review.
References
-
- Al MD, Van Houwelingen AC, Kester ADM, Hasaart THM, De Jong AEP, Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr. 1995;74:55–68. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
-
- Alwan S, Reefhuis J, Rasmussen SA, Olney R, Friedman JM. Use of selective serotonin reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 2007;356:2684–2692. - PubMed
-
- Benisek D, Shabert J, Skornik R. Dietary intake of polyunsaturated fatty acids by pregnant or lactating women in the United States. Obstet Gynecol. 2000;95:77–78.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials